Sign inJoin waitlistJoin the waitlist

Frank Ondrey

Professor · University of Minnesota

Credentials: · · · · ·

History

University of Minnesota
Present

Otolaryngology - Head and Neck Surgery
University of Minnesota
1990–1995
General Surgery
Hennepin Healthcare
1986–1991
Rush Medical College
1985–1989

Research

Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
Clinical Cancer Research · 1999 · 428 citations
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer
Journal of Clinical Oncology · 2014 · 419 citations
Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck
Cancer Research · 2004 · 329 citations

Nelson Rhodus
12 papers
CW
Carter Van Waes
9 papers
Patrick Gaffney
7 papers
AE
Andrew Elton
6 papers · 6 as a resident
DD
Dianne Duffey
6 papers
LM
Lindsey Mortensen
5 papers · 5 as a resident
Diego Preciado
4 papers
LH
Laurie Herscher
4 papers
SB
Seth Buryska
4 papers
WM
Wendy Miller
4 papers · 4 as a resident
AH
Anna Haynes
3 papers · 1 as a resident
EG
Emiro Granados
3 papers

Grants

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
National Cancer Institute · R01
Contact PI · $1.7M · University of Minnesota
2022–2027
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $242.4K · University of Minnesota
1998–2024
No. 73 a Phase Iia Cancer Prevention Trial of the Ppar/ Agonist Piogli-261015000
National Cancer Institute · N01
Contact PI · University of Minnesota

Clinical trials

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
Principal investigator · Recruiting · Phase 2
University of Minnesota
2025–2027
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
2018–2019
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Principal investigator · Terminated · Phase 2
Masonic Cancer Center, University of Minnesota
2006–2008
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2003–2008